CRSP · CRISPR Therapeutics AG
$59.50
+1.38 (+2.37%)
At close · Aug 21
Market Cap
$5.75B
Shares
96.69M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-03 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-04 | — | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| DEF 14A | 2026-04-21 | 2026-06-04 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 10-K | 2026-02-12 | 2025-12-31 | |
| 8-K | 2026-02-12 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-10-15 | — | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-08-04 | — | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-09 | 2025-06-05 | |
| 8-K | 2025-05-19 | — | |
| 8-K | 2025-05-06 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| DEF 14A | 2025-04-16 | 2025-06-05 | |
| 8-K | 2025-03-26 | 2025-03-24 | |
| 8-K | 2025-02-11 | — | |
| 10-K | 2025-02-11 | 2024-12-31 | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-06-03 | 2024-05-30 | |
| 8-K | 2024-05-23 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-09 | 2024-05-30 | |
| 8-K | 2024-02-21 | — | |
| 10-K | 2024-02-21 | 2023-12-31 | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2024-01-16 | — | |
| 8-K | 2023-12-19 | 2023-12-14 | |
| 8-K | 2023-12-15 | — | |
| 8-K | 2023-12-13 | 2023-12-12 | |
| 8-K | 2023-12-08 | — | |
| 8-K | 2023-12-04 | — | |
| 8-K | 2023-11-16 | 2023-11-15 | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-09-07 | 2023-09-04 | |
| 10-Q | 2023-08-07 | 2023-06-30 |
Showing 1–50 of 118 filings
Key facts
CIK
1674416
CUSIP
H17182108
13F (30d)
429 filings
417 filers
Visit website
Investor relations